TRIUMPH-4 Phase 3: 28.7% weight loss at 68 weeks. The largest ever in a Phase 3 obesity trial. Seven more readouts coming in 2026.
This post is available to premium subscribers. Subscribe to access the full article and all premium content.
Every Tuesday: one landmark study, one protocol, one regulatory update. Plus new research posts as they publish. Free.
For research and educational purposes only · Not medical advice · Consult a qualified physician before any human use